C-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells

Nature Cell Biology

Volumn 3, Issue 3, 2001, Pages 283-288

  Gavioli, Riccardo ^a,b   Frisan, Teresa ^a   Vertuani, Simona ^a,b   Bornkamm, Georg W ^c   Masucci, Maria G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF FERRARA   (Italy)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; MYC PROTEIN; PROTEASOME; PROTEASOME INHIBITOR; PROTEINASE; SUBTILISIN; UBIQUITIN;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL SURVIVAL; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; EPSTEIN BARR VIRUS; GENE ACTIVATION; GENE OVEREXPRESSION; LYMPHOMA CELL; MALIGNANT TRANSFORMATION; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DEGRADATION; VIRUS RECOMBINANT;

APOPTOSIS; B-LYMPHOCYTES; BURKITT LYMPHOMA; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DNA; DNA FRAGMENTATION; ENDOPEPTIDASES; GENES, MYC; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOBLOTTING; MULTIENZYME COMPLEXES; OLIGOPEPTIDES; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; SERINE ENDOPEPTIDASES; SULFONES; UBIQUITINS;

HUMAN HERPESVIRUS 4;

EID: 0035097842     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/35060076     Document Type: Article

References (38)

1. The ubiquitin-proteasome pathway: On protein death and cell life. EMBO J ensates for loss of proteasome function
2. The proteasome: Paradigm of a self-compartmentalizing protease
3. Cancer cell cycles
4. A giant protease with potential to substitute for some functions of the proteasome
5. A proteolytic system that compensates for loss of proteasome function
6. Specific chromosomal translocations in the genesis of B-cell lymphomas in mice and men
7. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells
8. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines
9. Phenotype-dependent differences in proteasome subunit composition and cleavage specificity in B cell lines
10. Variations in proteasome subunit composition and enzymatic activity in B-lymphoma lines and normal B-cells
11. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: Coordinate up-regulation of peptide transporters and HLA-class I antigen expression
12. 1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2
13. c-Myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1
14. Cell cycle activation by c-myc in a Burkitt's lymphoma model cell line
15. Ubiquitin-dependent protein degradation
16. A ubiquitin C-terminal isopeptidase that acts on polyubiquitin chains
17. The yeast DOA4 gene encodes a deubiquitinating enzyme related to the product of the tre-2 oncogene
18. Control of cell fate by a deubiquitinating enzyme encoded by the fat facet gene
19. DUB-1, a novel deubiquitinating enzyme with growth-suppressing activity
20. The level of C/EBP protein is critical for cell migration during drosophila oogenesis and is tightly controlled by regulated degradation
21. Purification, substrate specificity, and classification of tripeptidyl peptidase II
22. Characterisation and inhibition of a cholecystokinin-inactivating serine peptidase
23. Proteins of the Myc network: Essential regulators of cell growth and differentiation
24. Myc function and regulation
25. Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway
26. Destruction of Myc by ubiquitin-mediated proteolysis: Cancer associated and transforming mutations stabilize Myc
27. c-Myc proteolysis by the ubiquitin-proteasome pathway: Stabilization of c-Myc in Burkitt's lymphoma cells
28. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmocytoma
29. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes
30. Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata
31. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus
32. Endemic Burkitt's lymphoma: Phenotypic analysis of tumour biopsy cells and of the derived tumour cell lines
33. Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with ethnic origin
34. Activation of the cell death program by inhibition of proteasome function
35. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes
36. Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes
37. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
38. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome